Budmail 420 Launches Unique Cannabis Advent Calendar
Budmail 420 announced that they have launched a cannabis advent calendar in Canada.
TORONTO, Nov. 13, 2022 (GLOBE NEWSWIRE) -- Heard of wine advent calendars, or chocolate ones, or even beer versions? Now, thanks to Budmail 420, customers can get their very own cannabis advent calendar in Canada.
Calendars feature 20 days of edibles, pre-rolls, grams of flower, and four days of cannabis accessories. Each one of those wonderful little goodies is tucked inside of a reusable cardboard box and marked as you countdown to Christmas.
"The company has seen the success of unique advent calendars in other industries," said Dylan Fawcett, President and CEO of Budmail 420. "This was a way that we could provide customers with a fun and engaging gift that they can enjoy for an entire month! I am looking forward to hearing from customers on how they like the surprises and different products."
Each box is filled with $250 worth of cannabis products and costs $265 before taxes. "These beautiful boxes are being filled by a partner dispensary with high quality products with a different product each day. Should you purchase a second box, will have the same great value but the products per day will be different than what is in the first box," said Fawcett.
Budmail 420 is working with dispensary partners to fill their regular edition of customized weed subscription boxes. Currently, the advent box is only available in Canada, but the Budmail 420 team is working to expand the service area and provide subscription boxes where legal to anyone interested.
The supply of the weed advent calendars is limited this year, so be sure to purchase yours today at Budmail 420. Delivery will take place the last week of November so that customers can enjoy on December 1st.
About Budmail 420
Budmail 420, founded in 2003, is a cannabis subscription service that operates in North America. The company allows customers to choose between four boxes; Puff (can include flower, pre-rolls, and vapes), Edible, CBD (can be topicals, flower, vapes, edibles), and sampler (a bit of everything). The box can be customized to meet each customers preference along with one of our favorite accessories, and $10 off your next purchase at the dispensary that is featured.
Contact Information:
Dylan Fawcett
CEO
dylanfawcett@budmail420.com
+1 (415)-851-5420
Related Images
To view this piece of content from cdn.newswire.com, please give your consent at the top of this page.
Image 1: weed advent calendar 2022
weed advent calendar 2022
This content was issued through the press release distribution service at Newswire.com.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Reporting of transactions made by members of the Board of Directors or Executive Management or their Closely Associated Persons1.5.2024 15:38:29 CEST | Press release
Pursuant to the Market Abuse Regulation, article 19, Svitzer Group A/S, CVR-no. 44 79 14 47, (“Svitzer Group” or the “Company”) hereby notifies receipt of information of the following transactions made by members of the Board of Directors or Executive Management in Svitzer Group or their closely associated persons in Svitzer Group’s shares admitted to trading and official listing on Nasdaq Copenhagen A/S. About Svitzer Svitzer is a leading, global towage and marine services provider. The core business is to assist large seaborne vessels in manoeuvring in and out of ports and terminals to berth and unberth. With more than 450 vessels, Svitzer’s services play a crucial role as part of critical port infrastructure. Svitzer was founded in 1833 and serves approximately 2,000 customers in more than 140 ports and 40 terminals across 37 countries. Read more on www.svitzer.com. For further information, please contact: Anders Crillesen Head of Global Communications E: anders.crillesen@svitzer.co
Suspension af udvalgte afdelinger den 6. maj 20241.5.2024 14:52:03 CEST | pressemeddelelse
Det skal oplyses, at nedenstående afdelinger vil være suspenderet for handel mandag den 6. maj 2024. ISINOrder book codeAfdelingsnavn før ændringAfdelingsnavn efter ændringDK0060254043SPVINONye obligationsmarkederINDEX Emerging Market Bonds LokalvalutaDK0060254126SPVINOAKKKLANye obligationsmarkeder Akk. – KL AINDEX Emerging Market Bonds Lokalvaluta Akk. – KL A Suspension af disse afdelinger kommer i forlængelse af tidligere fondbørsmeddelelse den 19. april 2024 vedrørende ædnringer i ovenstående fonde. Det vurderes, at det ikke er hensigtmæssigt at stille priser i markedet på ovenstående afdelinger den 6. maj 2024, hvorfor suspensionen forlænges til og med denne dag. Eventuel henvendelse vedrørende denne meddelelse kan rettes til npa.pm@nykredit.dk, cc jna@nykredit.dk Med venlig hilsen Morten Skipper Direktør, ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg
Alternus Clean Energy set to Acquire Over 80 MWp of Operating Solar PV across eight states in the U.S.1.5.2024 14:40:00 CEST | Press release
On completion will be immediately EBITDA accretive FORT MILL, S.C., May 01, 2024 (GLOBE NEWSWIRE) -- Alternus Clean Energy, Inc. (NASDAQ: ALCE) (“Alternus” or the “Company”), a leading utility-scale transatlantic, clean energy independent power producer (IPP) today announced the signing of definitive agreements with a U.S. based fund to acquire over 80 MWp of operating portfolio spanning across the U.S. The Portfolio consists of 33 projects, distributed across eight states, showcasing a geographical diversification within the U.S. The portfolio has significant long-term agreements (average remaining term of over 12 years) with 16 different counterparties. Notably, approximately 20% of these fall within the AAA and AA rating categories, such as Duke Energy, enhancing the financial stability and predictability of revenue streams. The Portfolio is expected to generate an average of $6.7 million of revenue and $5.1 million (before improvements) of operating income annually and represents a
Novo Nordisk A/S - share repurchase programme1.5.2024 14:30:46 CEST | Press release
Bagsværd, Denmark, 1 May 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme initiated 6 February 2024, Novo Nordisk will repurchase B shares for an amount up to DKK 2.1 billion in the period from 6 February 2024 to 30 April 2024. The programme is now concluded. Since the announcement 22 April 2024, the following transactions have been made: Number of B sharesAverage purchase priceTransaction value, DKKAccumulated, last announcement2,133,5001,846,074,35122 April 202442,000859.5736,101,80523 April 202442,000881.9837,043,21124 April 202441,000885.2536,295,24925 April 202441,00
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics1.5.2024 14:01:00 CEST | Press release
BOSTON and LONDON, May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced leadership changes, including the appointment of experienced life sciences entrepreneur Samir R. Patel, M.D. as interim CEO. Rachelle Jacques will step down as Akari’s Chief Executive Officer effective today. Melissa Bradford-Klug will step down as Akari’s Chief Operating Officer effective today. In connection with Ms. Jacques’ departure, Akari’s board of directors (the “Board”) has appointed Dr. Patel as Interim Chief Executive Officer. Dr. Patel has served as a member of the Board since December 2023. “I am honored to be appointed interim CEO by the Akari Board of Directors. My immediate goals are timely completion of the previously announced merger between Akari Therapeutics and Peak Bio, implementation of the portfolio prioritization agreed upon by the boards of both companies whil